Protein C concentrate in the treatment of warfarin-induced skin necrosis in the protein C deficiency.
K
K
Lewandowski
K
K
Zawilska
D000074:Acenocoumarol / Q000009:adverse effects* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005260:Female; D006493:Heparin / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D009336:Necrosis; D010314:Partial Thromboplastin Time; D010949:Plasma; D011486:Protein C / Q000627:therapeutic use*; D020151:Protein C Deficiency; D012867:Skin / Q000473:pathology*; D013924:Thrombophlebitis / Q000188:drug therapy; D014859:Warfarin / Q000009:adverse effects*
D011486:Protein C; D014859:Warfarin; D006493:Heparin; D000074:Acenocoumarol